In patients with impaired renal function or fast-deteriorating eGFR at baseline, lucerastat was associated with a marked ...
Pfizer Inc. (NYSE: PFE) today announced positive results from Cohort 3, a separate randomized cohort of the pivotal ...
On the enterprise side, bolstered by a major launch on Microsoft Foundry, Claude now speaks fluent medical ...
Approval is supported by data from the DEVOTE study which showed the benefit of the SPINRAZA 50 mg and 28 mg regimen in both ...
In patients with impaired renal function or fast-deteriorating eGFR at baseline, lucerastat was associated with a marked attenuation of kidney function loss, suggesting a potential disease-modifying e ...
A research team presents an overview of recent advances in the microbial biosynthesis of L-tryptophan (L-Trp) and its ...
Allschwil, Switzerland - January 12, 2026Idorsia Ltd (SIX: IDIA) announces that Srishti Gupta, MD, Chief Executive Officer of Idorsia, will present at the 44th Annual J.P. Morgan Healthcare Conference ...
Sensorineural hearing loss (SNHL) is a highly prevalent sensory disorder globally, affecting over 1.5 billion people, with a ...
The 43-day shutdown of the U.S. government in October and November 2025 complicated lots of things for lots of people, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback